✦ For everyone, free.

Practical knowledge for real and everyday life

Home

Cancer Cell Biology

How normal cells become cancerous, from genetic and epigenetic alteration to invasion and metastatic behavior.

Cancer Cell Biology is the branch of cell biology dedicated to the study of the cellular and molecular mechanisms that transform normal cells into malignant ones, examining how disruptions in the regulation of cell growth, division, differentiation, and death give rise to uncontrolled proliferation, tissue invasion, and metastasis. It investigates the genetic mutations, epigenetic alterations, and signaling abnormalities that drive tumorigenesis, as well as the interactions between cancer cells and their surrounding microenvironment.


The Transformation of Normal Cells

Loss of Growth Control

Normal cells divide only in response to specific growth signals and are subject to regulatory checkpoints that halt division when errors are detected. Cancer cells acquire the ability to proliferate independently of external growth signals and to bypass the checkpoints that would otherwise arrest or eliminate a damaged cell.

Genomic Instability

Mutations affecting DNA repair mechanisms often accompany cancer development, leading to genomic instability that accelerates the accumulation of further mutations. This instability increases the likelihood that additional oncogenic changes will arise within a growing cell population.

Oncogenes and Tumor Suppressor Genes

Cancer arises through the activation of oncogenes, which promote cell proliferation when mutated or overexpressed, and the inactivation of tumor suppressor genes, which normally restrain cell division or trigger programmed cell death.

Proto-oncogene Mutation Oncogene Uncontrolled proliferation

Hallmarks of Cancer Cells

Sustained Proliferative Signaling and Evasion of Growth Suppressors

Cancer cells generate their own growth signals or become hypersensitive to existing ones, while simultaneously disabling the tumor suppressor pathways that would normally limit their division.

Resistance to Cell Death and Replicative Immortality

Malignant cells acquire resistance to apoptosis, the programmed cell death pathway that eliminates damaged or abnormal cells, and often reactivate telomerase, an enzyme that maintains chromosome ends and allows unlimited replicative capacity.

Angiogenesis and Invasion

Tumors induce the formation of new blood vessels, a process called angiogenesis, to supply the nutrients and oxygen needed for continued growth. Advanced cancer cells also acquire the ability to invade surrounding tissue and enter the bloodstream or lymphatic system, enabling metastasis to distant organs.

Tumor Angiogenesis Metastasis

The Tumor Microenvironment

Stromal and Immune Interactions

Cancer cells exist within a complex microenvironment composed of stromal cells, immune cells, blood vessels, and the extracellular matrix. These components can either restrain tumor growth or, when co-opted by the tumor, actively support proliferation, invasion, and immune evasion.

Immune Evasion

Cancer cells develop mechanisms to escape detection and destruction by the immune system, including the downregulation of antigen presentation and the expression of inhibitory signals that suppress the activity of immune cells such as T lymphocytes.


Metabolic Reprogramming

Altered Energy Metabolism

Cancer cells frequently rely on aerobic glycolysis, converting glucose into lactate even in the presence of sufficient oxygen, a phenomenon known as the Warburg effect. This metabolic shift supports the rapid biosynthesis of macromolecules required for continuous proliferation.

Glucose Lactate + ATP (aerobic conditions)

Approaches to Studying Cancer Cells

Experimental Models

Researchers investigate cancer cell biology using cultured cell lines, three-dimensional organoid systems, and animal models, allowing controlled analysis of tumor growth, drug response, and metastatic behavior.

Molecular Profiling

Genomic sequencing, transcriptomic analysis, and proteomic profiling are used to characterize the mutational landscape and molecular signatures of tumors, informing the classification of cancer subtypes and the development of targeted therapies.

Content in this section